Australian Technical Advisory Group on Immunisation (ATAGI)

Role

ATAGI's role is to:

advise the Minister for Health on the medical administration of vaccines available in Australia, including those available through the National Immunisation Program (NIP)
provide advice to research organisations on current immunisation research and areas that need more research
provide industry sponsors with pre-submission advice for potential submissions to the Pharmaceutical Benefits Advisory Committee (PBAC) on vaccine effectiveness and use in Australia. ATAGI advice must be sought prior to a sponsor making a submission to the PBAC (see parallel processing requirements for PBAC vaccine submissions and pre-submission advice for industry sponsors wishing to make a PBAC submission)
consult with relevant organisations to produce the Australian Immunisation Handbook
consult with relevant organisations in implementing immunisation policies, procedures and vaccine safety.

For more detail, take a look at:

Members

ATAGI members as at 1 July 2021.

Voting members
Voting members
Name	Area of expertise	Position
A/Prof Nigel Crawford	Chair, Vaccine Safety, Special Risk Groups	Director, Surveillance of Adverse Events Following Vaccination in the Community (SAEFVIC), Murdoch Children’s Research Institute Head Immunisation Services Royal Children’s Hospital, Melbourne
Prof Michelle Giles	Deputy Chair, Infectious Disease Physician, Maternal Immunisation	Infectious Diseases Physician (Alfred Health, Monash Health, Royal Women’s Hospital, Sunshine Hospital) Adult Immunisation Physician (Alfred Health and Sunshine Hospital)
A/Prof Christopher Blyth	Co-Chair for COVID‑19, Paediatric Infectious Diseases, Clinical Microbiology	Paediatrician Infectious Diseases Physician and Clinical Microbiologist, University of Western Australia, Telethon Kids Institute, Perth Children's Hospital and PathWest Laboratory
Prof Allen Cheng	Co-Chair for COVID‑19, Epidemiology, Public Health	Infectious Disease Physician and Director, Infection Prevention Healthcare Epidemiology Unit, Alfred Health
Ms Karen Bellamy	Paediatric, Adult and Maternal Immunisation, Vaccination Procedures	Immunisation Nurse Practitioner, Immunisation, Research, COVID Vaccine Safety, Monash Health, SEPHU
Prof Katie Flanagan	Infectious Diseases	Head of Infectious Diseases, Launceston General Hospital, Clinical Professor, University of Tasmania, Adjunct Professor, RMIT Adjunct Associate Professor, Monash University
Dr Katherine Gibney	Infectious Diseases Physician, Epidemiology	Infectious Diseases Physician, Department of Infectious Diseases, The Austin Hospital NHMRC Early Career Fellow, The Peter Doherty Institute for Infection and Immunity
Dr Penelope Burns	General Practitioner	Clinical Associate Professor, Australian National University Conjoint Senior Lecturer Western Sydney University
Prof Cheryl Jones	Paediatrics	Head of School and Dean, Sydney Medical School Faculty of Medicine and Health, University of Sydney
Adj. A/Prof Tony Korman	Infectious Diseases, Microbiology	Director, Monash Infectious Diseases and Microbiology, Monash Health
A/Prof Bette Liu	Epidemiology, Public Health	Associate Professor and NHMRC Career Development Fellow, UNSW Sydney
Dr Nicholas Silberstein	General Practitioner	General Practitioner, Victoria
Dr James Wood	Infectious Diseases Epidemiology, Population Health	Associate Professor, School of Population Health, UNSW Sydney
Ms Diane Walsh	Consumer Health Issues	Consumers Health Forum, Chair of Northern Territory, Primary Health Network
Prof Tom Snelling	Paediatrics and special risk groups	Director of Health and Clinical Analysis, University of Sydney Infectious Diseases Physician, Sydney Children’s Hospital Foundation
Ms Kristy Cooper	Senior Nurse Practitioner	Aboriginal, Torres Strait Islander Representative

Ex-officio members

Name	Area of expertise	Position
Mr Darius Everett	Representative from Department of Health	A/g Assistant Secretary, Immunisation Branch, Department of Health
Dr Ting Lu	Representative from the Therapeutic Goods Administration	Office of Medicines Authorisation Market Authorisation Group, Therapeutic Goods Administration
Prof Kristine Macartney	National Centre for Immunisation Research and Surveillance (NCIRS)	Director, National Centre for Immunisation Research and Surveillance Paediatrician and Infectious Diseases Specialist
Dr Robyn Gibbs	National Immunisation Committee (NIC)	Manager, Immunisation Program, Department of Health, Weston Australia
Dr Vanessa Johnston	Communicable Diseases Network Australia (CDNA)	Deputy Chair, Communicable Diseases Network Australia, Public Health Specialist, Deputy Chief Health Officer, Public Health, Protection and Regulation
Prof. Andrew Wilson	Pharmaceutical Benefits Advisory Committee (PBAC)	Chair - Pharmaceutical Benefits Advisory Committee
Ms Jo Watson	Pharmaceutical Benefits Advisory Committee (PBAC)	Deputy Chair - Pharmaceutical Benefits Advisory Committee

Membership guidelines

Statements

COVID-19 vaccination statements

8 October 2021 – on the use of a 3rd primary dose of COVID-19 vaccine in individuals who are severely immunocompromised
23 September 2021 – on the need for additional doses of COVID-19 vaccines
27 August 2021 – on the use of COVID-19 vaccines in all young adolescents in Australia
9 August 2021 – on considerations for establishing drive-through COVID-19 vaccination clinic sites
2 August 2021 – regarding COVID-19 vaccines in the setting of transmission of the Delta variant of concern
24 July 2021 – response to NSW COVID-19 outbreak 24th July 2021
13 July 2021 – on the use of COVID-19 vaccines in an outbreak setting
17 June 2021 – on revised recommendations on the use of COVID-19 Vaccine AstraZeneca
9 June 2021 – joint statement between RANZCOG and ATAGI about COVID-19 vaccination for pregnant women
23 May 2021 – joint statement on Thrombosis with Thrombocytopenia Syndrome (TTS) and the use of COVID-19 Vaccine AstraZeneca
23 April 2021 – on use of COVID-19 vaccines following review of vaccine safety data and benefits
8 April 2021 – on AstraZeneca vaccine in response to new vaccine safety concerns
2 April 2021 – on COVID-19 vaccination and a reported case of thrombosis
2 April 2021 – for consumers on a specific clotting condition being reported after COVID-19 vaccination
25 March 2021 – for health care providers on suitability of COVID-19 vaccination in people with history of clotting conditions
19 March 2021 – statement and clinical guidance on AstraZeneca COVID-19 vaccine following European Medicines Agency (EMA) safety review
16 March 2021 – in response to European decisions about the AstraZeneca vaccine

Weekly COVID-19 meeting updates

Meetings

Australian Technical Advisory Group on Immunisation (ATAGI) – Meetings

A collection of ATAGI meeting agendas and bulletins.

ATAGI advice

COVID-19 vaccination – Provider resources

COVID-19 vaccination – Provider resources

Read and download clinical guidance and other resources for COVID-19 vaccines provided by the Australian Technical Advisory Group on Immunisation (ATAGI).

COVID-19 vaccination – Patient resources

This collection contains resources for patients receiving a COVID-19 vaccination.

Related committees and groups

Australian Technical Advisory Group on Immunisation (ATAGI) COVID-19 Working Group

View the purpose and membership of the Australian Technical Advisory Group on Immunisation (ATAGI) COVID-19 Working Group.

Contact

Australian Technical Advisory Group on Immunisation (ATAGI) secretariat

Contact the secretariat for the Advisory Technical Advisory Group on Immunisation (ATAGI) or further information on the committee or previous meeting agendas and bulletins (meeting minutes)

Australian Technical Advisory Group on Immunisation (ATAGI)

Postal addresses:

Immunisation Branch

GPO Box 9848 – MDP 13

Canberra ACT 2601

View contact

Last updated:

25 October 2021

Tags:

Immunisation